RxDoctor Payments Data

Durga Mulpuri, MD

Family Medicine · Grosse Pointe Park, MINPI 1891786216

Payments from drug & device makers

$2,479in general payments, 2019–2025

Across 159 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AstraZeneca$551
  • GSK$132
  • Pfizer$120
  • Amgen$92
  • Lilly USA, LLC$75
  • plus $460 from 15 others

What the payments were for

  • Food & beverage$2,479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,479 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$54,833
Medicare patients
132
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide260$374,432
JardianceEmpagliflozin119$135,520
FarxigaDapagliflozin Propanediol131$128,947
EliquisApixaban131$120,762
TrulicityDulaglutide68$119,290
JanuviaSitagliptin Phosphate108$108,853
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$53,673
MounjaroTirzepatide35$47,801
EntrestoSacubitril/Valsartan41$41,735
Repatha SureclickEvolocumab38$26,007
XareltoRivaroxaban33$25,266
Breo ElliptaFluticasone/Vilanterol35$20,618
LinzessLinaclotide15$15,270
Lantus SolostarInsulin Glargine,hum.Rec.Anlog110$12,701
SymbicortBudesonide/Formoterol Fumarate48$11,727

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,049$374,432260 claims
Lilly USA, LLCTrulicity, Mounjaro$75$167,090103 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$551$151,101196 claims
Boehringer IngelheimJardiance, Spiriva Respimat$52$144,246130 claims
PfizerEliquis$120$120,762131 claims
MerckJanuvia, Janumet Xr$20$112,800119 claims
GSKTrelegy Ellipta, Breo Ellipta$132$74,291108 claims
NovartisEntresto$25$41,73541 claims
Johnson & JohnsonXarelto$15$25,26633 claims
AbbVieLinzess$55$15,27015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Grosse Pointe Park

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →